Dongwha Pharm
Launch date
Employees
Market cap
AUD282m
Enterprise valuation
AUD252m (Public information from Sep 2024)
Share price
KRW7870 000020.KS
South Korea (HQ)
Financials
Estimates*
| KRW | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | 307.2b | 272.1b | 293.0b | 340.4b | 361.1b |
| % growth | - | - | - | (11 %) | 8 % | 16 % | 6 % |
| EBITDA | - | - | 28.6b | 35.2b | 37.4b | 43.9b | 43.0b |
| % EBITDA margin | - | - | 9 % | 13 % | 13 % | 13 % | 12 % |
| Profit | - | - | 9.4b | 28.5b | 17.9b | 20.4b | 27.4b |
| % profit margin | - | - | 3 % | 10 % | 6 % | 6 % | 8 % |
| EV / revenue | - | - | 0.4x | 1.6x | 1.0x | 0.5x | 0.7x |
| EV / EBITDA | - | - | 4.1x | 12.4x | 7.9x | 3.5x | 5.6x |
| R&D budget | - | - | 16.3b | 16.9b | 17.3b | 19.3b | 21.5b |
| R&D % of revenue | - | - | 5 % | 6 % | 6 % | 6 % | 6 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
